Jamjoom Pharmaceuticals Factory Co (SAU:4015) Tax Provision: ﷼-31 Mil (TTM As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

SAU:4015 Jamjoom Pharmaceuticals Factory Co SAU:4015
98 GF Score
Price ﷼142.70
GF Value ﷼179.00
Valuation Modestly Undervalued
! 1 Warning Sign
View Full Analysis

What is Jamjoom Pharmaceuticals Factory Co Tax Provision?

Jamjoom Pharmaceuticals Factory Co SAU:4015 +1.35% 98 Tax Provision is ﷼-31 Mil as of Jun. 2026. GuruFocus rates SAU:4015 with a GF Score™ of 98/100 and a GF Value™ of ﷼179.00 (Modestly Undervalued). The stock has 1 warning sign investors should review.

Jamjoom Pharmaceuticals Factory Co's tax provision for the three months ended in Jun. 2026 was ﷼-9 Mil. Its tax provision for the trailing twelve months (TTM) ended in Jun. 2026 was ﷼-31 Mil.

Jamjoom Pharmaceuticals Factory Co Tax Provision Historical Data

* Premium members only.

The historical data trend for Jamjoom Pharmaceuticals Factory Co's Tax Provision can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Jamjoom Pharmaceuticals Factory Co Tax Provision Chart

Jamjoom Pharmaceuticals Factory Co Annual Data
Trend Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Tax Provision
Get a 7-Day Free Trial -17.39 -15.00 -23.40 -26.13 -29.30

Jamjoom Pharmaceuticals Factory Co Quarterly Data
Jun21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Tax Provision Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -7.01 -6.67 -8.84 -6.73 -8.59
SAU:4015
98GF Score
Jamjoom Pharmaceuticals Factory Co SAU:4015
Tax Provision is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Jamjoom Pharmaceuticals Factory Co Tax Provision Calculation

Tax to be paid.

Tax Provision for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ﷼-31 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Tax Provision →
What does a Tax Provision of ﷼-31 Mil mean?
Jamjoom Pharmaceuticals Factory Co (SAU:4015) has a Tax Provision of ﷼-31 Mil as of Jun. 2026. Provision for taxes is the amount of tax the company owes based on pre-tax income. View historical data on Jamjoom Pharmaceuticals Factory Co and its competitors.
Is Jamjoom Pharmaceuticals Factory Co's Tax Provision too high?
Jamjoom Pharmaceuticals Factory Co's current Tax Provision is ﷼-31 Mil. Overall, Jamjoom Pharmaceuticals Factory Co has a GF Score™ of 98/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Jamjoom Pharmaceuticals Factory Co's Tax Provision compare to ZTS and UTHR?
Jamjoom Pharmaceuticals Factory Co's Tax Provision of ﷼-31 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Tax Provision for a Drug Manufacturers company?
A good Tax Provision depends on the Drug Manufacturers industry context. However, Tax Provision should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Tax Provision mean?
A high Tax Provision can signal that a stock is expensive relative to its fundamentals. Provision for taxes is the amount of tax the company owes based on pre-tax income. View historical data on Jamjoom Pharmaceuticals Factory Co and its competitors. Jamjoom Pharmaceuticals Factory Co's current Tax Provision is ﷼-31 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Jamjoom Pharmaceuticals Factory Co stock overvalued right now?
Based on GuruFocus' analysis, Jamjoom Pharmaceuticals Factory Co (SAU:4015) is currently considered Modestly Undervalued. The stock's GF Value™ is ﷼179.00, compared to a current price of ﷼142.70 — trading 20.3% below its estimated fair value. The current Tax Provision is ﷼-31 Mil. Jamjoom Pharmaceuticals Factory Co's overall GF Score™ is 98/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Tax Provision calculated?
Tax Provision is calculated from a company's financial statements. For Jamjoom Pharmaceuticals Factory Co (SAU:4015), the current Tax Provision is ﷼-31 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Jamjoom Pharmaceuticals Factory Co (SAU:4015) Overvalued in 2026?

Based on GuruFocus' analysis, Jamjoom Pharmaceuticals Factory Co stock appears to be undervalued. The current stock price of ﷼142.70 is trading 20.3% below its estimated GF Value™ of ﷼179.00. GuruFocus considers Jamjoom Pharmaceuticals Factory Co to be Modestly Undervalued.

Key valuation signals for SAU:4015:

  • Tax Provision: ﷼-31 Mil
  • GF Value™: ﷼179.00 vs. price of ﷼142.70 (20.3% below fair value)
  • GF Score™: 98/100 with 1 warning sign

No single metric tells the full story. See the SAU:4015 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Jamjoom Pharmaceuticals Factory Co Business Description

Address Corniche Road, P.O. Box No. 6267, 1234 Al Hamra District, Jeddah, SAU, 21442
Jamjoom Pharmaceuticals Factory Co is engaged in producing human medicines, nutraceuticals, antibiotics, general analgesics, medicines for treatment of cough, allergy, asthma, heart diseases, blood pressure, diarrhea, vomiting, ulcer and acidity, treatment of various skin infections, cancer diseases, eye drops and ointments and cosmeceuticals. Geographically the company has a presence in the Kingdom of Saudi Arabia, the Gulf, Iraq, Egypt, North Africa, and other export markets.
98GF Score

Get the complete analysis for SAU:4015

Tax Provision is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

﷼142.70
Price
﷼179.00
GF Value